Consensus CT delineation guidelines for head and neck organs at risk from eight cooperative groups, with anatomical descriptions and example images. Citation checked against Crossref; content not yet reviewed by DoseLab.
Pituitary Gland
Dose constraints
High-Grade Glioma
| Schedule | Constraint | Source |
|---|---|---|
| 60 Gy / 30 fx Standard course | Mean ≤45 Gy | EPTN 2018 (Lambrecht) |
Include the pituitary stalk.
Quoted from eviQ 409, checked 2026-09-25. Full table with references →
Anatomy
A small gland in the sella turcica of the sphenoid bone, just below the optic chiasm.
Function in the body
A small gland that makes hormones controlling growth, the thyroid, the adrenal glands and the reproductive glands, often called the body's master gland.
Why it matters
Radiation can cause hypopituitarism — reduced hormone production that may appear years after treatment. It matters mainly for nasopharynx and sinonasal cancers, where the target can extend into or near the sphenoid sinus. In brain treatment it matters for targets near the sella and the base of the frontal and temporal lobes.
How to contour
Brouwer 2015 notes the gland is very small and generally hard to see on CT; the inner part of the sella turcica can be used as a bony surrogate, and its borders are easiest to set on the sagittal view. The EPTN 2018 atlas adds:
- Oval, up to 12 mm from top to bottom, sitting in the sella turcica.
- The cavernous sinuses border it at the sides (well seen with IV contrast); the brain lies just above it, connected by the pituitary stalk to the hypothalamus.
Because it is so small, Brouwer 2015 suggests expanding it by 5 mm when calculating DVH data, to make the numbers more consistent (while avoiding overlap with the PTV), and recommends a contrast CT with slices of 2 mm or less.
The European Particle Therapy Network contouring atlas for brain organs at risk on CT and MRI, with anatomical descriptions and boundaries. Citation checked against Crossref.
Further reading
- Lee 2019 NPC guideline — International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma Source